Sumitomo Dainippon Pharma Co (DPM) Revenue
Sumitomo Dainippon Pharma Co Revenue
Sumitomo Dainippon Pharma Co had a revenue of 137.00B in the quarter ending Sep 30, 2026, with 5.79%. This bring the company's revenue in the last twelve months to 492.66B, Increased 3.76%. In the fiscal year ending Mar 31, 2026, Sumitomo Dainippon Pharma Co had annual revenue of 453.29B with 13.66% growth.
- Revenue (ttm)
- 492.66B
- Revenue Growth
- -0.25%
- P/S Ratio
- 0.01
- Revenue/Employee
- EUR 145,146,974
- Employees
- 3,123
- Market Cap
- EUR 4.79B
Revenue Chart
Sumitomo Dainippon Pharma Co Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 453.29B | 54.46B | 13.66% |
| Mar 31, 2026 | 398.83B | 84.27B | 26.79% |
| Mar 31, 2025 | 314.56B | -240.99B | -43.38% |
| Mar 31, 2024 | 555.54B | -4.49B | -0.80% |
| Mar 31, 2023 | 560.03B | 44.08B | 8.54% |
| Mar 31, 2022 | 515.95B | 33.22B | 6.88% |
| Mar 31, 2021 | 482.73B | 23.46B | 5.11% |
| Mar 31, 2020 | 459.27B | -7.57B | -1.62% |
| Mar 31, 2019 | 466.84B | 58.48B | 14.32% |
| Mar 31, 2017 | 408.36B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.